Naveen Karuvandan

Results of Phase III Randomized Trial for Use of Docetaxel as a Radiosensitizer in Patients With Head and Neck Cancer, Unsuitable for Cisplatin-Based Chemoradiation

P. Chaturvedi, A. Mahajan, P. Pai, 2023, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Low-cost oral metronomic chemotherapy versus intravenous cisplatin in patients with recurrent, metastatic, inoperable head and neck carcinoma: an open-label, parallel-group, non-inferiority, randomised, phase 3 trial.

A. Mahajan, A. Bhattacharjee, K. Prabhash, 2020, The Lancet. Global health.

Dexamethasone and exercise for cancer-related fatigue: A phase III randomized controlled trial.

K. Prabhash, V. Noronha, V. Patil, 2023, Journal of Clinical Oncology.